Matches in Wikidata for { <http://www.wikidata.org/entity/Q92023899> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q92023899 description "article scientifique publié en 2020" @default.
- Q92023899 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q92023899 description "bài báo khoa học" @default.
- Q92023899 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92023899 description "scientific article published on 17 April 2020" @default.
- Q92023899 description "wetenschappelijk artikel" @default.
- Q92023899 description "наукова стаття, опублікована 17 квітня 2020" @default.
- Q92023899 name "Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results" @default.
- Q92023899 name "Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results" @default.
- Q92023899 type Item @default.
- Q92023899 label "Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results" @default.
- Q92023899 label "Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results" @default.
- Q92023899 prefLabel "Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results" @default.
- Q92023899 prefLabel "Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results" @default.
- Q92023899 P1433 Q92023899-024B4ED7-39EE-4595-9FCD-AA8E6BA10757 @default.
- Q92023899 P1476 Q92023899-677C6D9B-8EBD-40BE-B775-A50C7775AE61 @default.
- Q92023899 P2093 Q92023899-05FB4885-3A1C-4345-B5A8-31F6AF7CB052 @default.
- Q92023899 P2093 Q92023899-31ABAA81-09E7-4FAF-ACAC-FB9ACC779819 @default.
- Q92023899 P2093 Q92023899-4F5BAC76-4A2F-4A3F-8A92-68E404462914 @default.
- Q92023899 P2093 Q92023899-59B0B229-C32B-4485-8EC1-87E5E34EB52C @default.
- Q92023899 P2093 Q92023899-5BB27E26-03BF-41B9-8792-3BC28476766D @default.
- Q92023899 P2093 Q92023899-648F395F-6923-4BFF-B85C-99E2283469DE @default.
- Q92023899 P31 Q92023899-2ED62B87-FB8E-4506-8243-164072780317 @default.
- Q92023899 P356 Q92023899-E13D0A24-7797-47A0-BA63-10A950BC7C3D @default.
- Q92023899 P50 Q92023899-47CFAC68-D56E-448F-B3F7-0EEC4A853975 @default.
- Q92023899 P577 Q92023899-18725B18-175E-4DFB-A6BC-2C0B1D1832DC @default.
- Q92023899 P698 Q92023899-874F8872-C9AE-46A7-964A-F0FD92B09F76 @default.
- Q92023899 P356 BJOPHTHALMOL-2020-316176 @default.
- Q92023899 P698 32303499 @default.
- Q92023899 P1433 Q13443571 @default.
- Q92023899 P1476 "Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results" @default.
- Q92023899 P2093 "Beau B Bruce" @default.
- Q92023899 P2093 "Charles C Wykoff" @default.
- Q92023899 P2093 "David M Brown" @default.
- Q92023899 P2093 "David S Boyer" @default.
- Q92023899 P2093 "TREX-DME Study Group" @default.
- Q92023899 P2093 "W Lloyd Clark" @default.
- Q92023899 P31 Q13442814 @default.
- Q92023899 P356 "10.1136/BJOPHTHALMOL-2020-316176" @default.
- Q92023899 P50 Q92023895 @default.
- Q92023899 P577 "2020-04-17T00:00:00Z" @default.
- Q92023899 P698 "32303499" @default.